While the COVID-19 pandemic accelerated the shift toward virtual care, the rapid growth of
Facility-0 utilizes reverse-engineered software drivers and custom hardware adapters to bridge the
For Tim Andrews, a 66-year-old patient with Type O blood, the experiment served as a vital bridge to a human transplant after two years of exhaustive waiting. This milestone, achieved through the collaboration of researchers and surgeons at Massachusetts General Hospital, signals a pivotal shift in
The architectural integrity of the human skeleton has long been regarded as a separate domain from the intricate cognitive networks of the mind, yet emerging research suggests the spine may serve as a profound biological mirror for neurological health. A comprehensive study from Johns Hopkins
Unlike the single-infusion protocol of CAR T-cells, the repeated administration of bispecific
Clinical practitioners frequently struggle with block-wise modality missingness, where budget
The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions of molecular simulations is a signal that biopharma’s approach to drug discovery is changing at a s…
The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at
In 2026, boards and customers are asking a direct question: can promising science be turned into
The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as
Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core
The proposed six-level autonomy framework provides a shared technical vocabulary for engineers and regulators to navigate the gradual handoff of tasks from humans to machines. This strategy, unveiled at the Roche Pharma Day, establishes a rigorous pathway for the integration of robotics and
Polydopamine nanotubes provide a versatile clinical tool that can disrupt cancer cell activity
Modern drug discovery is shifting away from labor-intensive physical screening toward a
